2025-11-25

Q2 2026 Results

Financial data not accessible in provided format

2025-08-26

Q1 2026 Results

Financial data not available in provided content

2025-02-25

Q3 2025 Results

2024-11-26

Q2 2025 Results

2024-08-27

Q1 2025 Results

2024-02-27

Q3 2024 Results

Financial figures not available in provided excerpt

2025-06-20

FY 2025 Results

2024-06-20

FY2024 Results

2025-11-18

Q2 FY2026 Earnings

Second quarter fiscal year 2026 financial results announced

2025-11-03

EVP Gregory Smith Retirement

Gregory L. Smith retiring Dec 2, 2025

2025-10-21

Annual Shareholder Meeting

12 directors elected, Articles of Association amended

2025-09-29

Euro Debt Offering

€1.5B notes issued (€750M 2030 @ 2.95%, €750M 2045 @ 4.20%)

2025-09-16

Euro Bond Issuance and Debt Redemption

€1.5B notes issued (€750M at 2.950% due 2030, €750M at 4.200% due 2045), redeeming €500M 2025 notes

2025-08-19

Q1 Earnings + Board Expansion

Q1 FY2026 results; Board expanded from 11 to 13 directors

2025-06-23

New Director Appointed

Dr. Joon Lee appointed to Board, expanding from 10 to 11 directors

2025-05-21

Q4 Earnings & Diabetes Spinoff

FY2025 results announced, Diabetes business separation into standalone public company

2025-03-17

Principal Accounting Officer Change

Jennifer Kirk resigns as Global Controller/PAO, Denise Blomquist appointed successor

2025-02-18

Q3 FY2025 Earnings

Third quarter fiscal year 2025 financial results announced

2025-01-21

CFO Appointment

Thierry Pieton named CFO effective March 3, 2025, $850K base salary

2024-11-19

Q2 FY2025 Earnings

Second quarter fiscal year 2025 financial results announced

2024-10-21

Annual Shareholder Meeting

10 directors elected, auditor ratified, executive compensation approved

2024-08-20

Q1 FY2025 Earnings

First quarter fiscal year 2025 financial results

2024-06-26

CFO Departure

Karen Parkhill resigned effective Aug 2, Gary Corona named interim CFO

2024-06-04

EVP Rob ten Hoedt Retirement

Rob ten Hoedt, EVP & President Global Regions, retiring June 28, 2024

2024-06-03

Euro Debt Offering

€3B notes issued across 4 tranches (2029-2053)

2024-05-23

Q4 and Full Year FY2024 Earnings

Full year and fourth quarter fiscal year 2024 financial results announced

2024-02-20

Q3 Earnings & Executive Departure

Q3 FY2024 results + Robert J. White departing April 26

2023-12-06

Terminated EOFlow Acquisition

Deal terminated due to multiple breaches by EOFlow